YOU SEARCHED BY...

Remove all

SEARCH BY...

Outsourcing Directory
Country

Outsourcing Directory

Medbio LLC





Company Headquarters

5346 36th Street Southeast
Grand Rapids, MI 49512
United States

Company Description

Medbio is an ISO 13485: 2016 certified contract manufacturer offering innovative manufacturing solutions for the Life Sciences. We specialize in precision injection molding, assembly, packaging, and design support. From components to full assemblies, Medbio has the knowledge and experience to solve your most difficult manufacturing challenges.

Outsourcing Directory

    Related Content

    • QIAGEN, Illumina Partner to Deliver Sequencing-Based In-Vitro Diagnostic Tests

      QIAGEN, Illumina Partner to Deliver Sequencing-Based In-Vitro Diagnostic Tests

      Partnership to accelerate the adoption of next-generation sequencing in clinical decision-making.
      Business Wire 11.15.19
    • Software & IT
      Veeva Acquires Physicians World

      Veeva Acquires Physicians World

      Companies join forces to deliver events management software and speakers bureau services.
      Veeva Systems 11.07.19
    • Healthcare Innovation Campus in Development for New York City

      Healthcare Innovation Campus in Development for New York City

      Roughly 300,000 square feet of space on Park Avenue South is being dedicated to the fight against disease.
      PR Newswire 11.07.19
    • Cook Regentec Enrolls First Patient in Clinical Trial of Critical Limb Ischemia Therapy

      Cook Regentec Enrolls First Patient in Clinical Trial of Critical Limb Ischemia Therapy

      Company is currently evaluating study sites for enrollment in the United States, Canada, and the European Union.
      Business Wire 10.23.19
    • FDA-Cleared Artificial Intelligence Breast Cancer Diagnosis System Launched by Paragon Biosciences

      FDA-Cleared Artificial Intelligence Breast Cancer Diagnosis System Launched by Paragon Biosciences

      Product will help provide a more accurate diagnosis for breast cancer patients, stemming from three decades of research at the University of Chicago.
      Business Wire 09.12.19
    • Trends, Opportunities, and Drivers in Early-Stage Life Sciences Investing

      Trends, Opportunities, and Drivers in Early-Stage Life Sciences Investing

      Despite trade wars and economic shifts in China and the EU, early-stage investing in life sciences remained strong in Q1 2019.
      Byron S. Kalogerou, Partner, McDermott Will & Emery 09.06.19
    • Co-Diagnostics Inc. Announces New Additions to Board of Directors

      Co-Diagnostics Inc. Announces New Additions to Board of Directors

      One new member is the founder and CEO of Hyperbolic Holdings, and the other is a senior partner in a private investment firm.
      Business Wire 08.14.19
    • 3. GE Healthcare

      3. GE Healthcare

      AT A GLANCE Rank: #3 (Last year: #3) $19.78 Billion ($122B total) Prior Fiscal: $19.02 Billion Percentage Change: +4% No. of Employees: 53,800 (283,000 total) Global Headquarters: Chicago, Ill. KEY EXECUTIVES H. Lawrence Culp, Jr.…
      07.30.19
    • 6. BD

      6. BD

      AT A GLANCE Rank: #6 (Last year: #9) $15.98 Billion Prior Fiscal: $12.10 Billion Percentage Change: +32.1% No. of Employees: 76,032 Global Headquarters: Franklin Lakes, N.J. KEY EXECUTIVES Vincent A. Forlenza, Chairman and CEO Christopher R. Re…
      07.30.19
    • Medtech Due Diligence: Proactive Steps to Successful Transactions

      Medtech Due Diligence: Proactive Steps to Successful Transactions

      The bar for due diligence in life sciences transactions is high and inching higher. Although today’s competitive deal landscape puts pressure on buyers and investors to move quickly, a strategic due diligence process that takes into account end…
      Robert H. Underwood, Ph.D., Partner, McDermott Will & Emery 06.13.19